Results for myelomonocytleukæmi translation from Danish to Bulgarian

Computer translation

Trying to learn how to translate from the human translation examples.

Danish

Bulgarian

Info

Danish

myelomonocytleukæmi

Bulgarian

 

From: Machine Translation
Suggest a better translation
Quality:

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Danish

Bulgarian

Info

Danish

kronisk myelomonocytleukæmi (cmml).

Bulgarian

хронична миеломоноцитна левкемия.

Last Update: 2012-04-10
Usage Frequency: 1
Quality:

Danish

kronisk myelomonocytleukæmi (cmml) med 10- 29% blaster i marv uden myeloproliferativ sygdom,

Bulgarian

хронична миеломоноцитна левкемия (cmml - chronic myelomonocytic leukaemia) с 10- 29% костномозъчни бласти без миелопролиферативно нарушение,

Last Update: 2012-04-10
Usage Frequency: 1
Quality:

Danish

klinisk virkning og sikkerhed vidazas virkning og sikkerhed blev undersøgt i et international, kontrolleret, open- label, randomiseret, komparativ, parallel- gruppe, fase 3- multicenterstudie (aza ph gl 2003 cl 001) hos patienter med: intermediær- 2 og højrisiko mds i henhold til international prognostic scoring system (ipss), refraktær anæmi med overskud af blaster (raeb), refraktær anæmi med overskud af blaster i transformation (raeb- t) og modificeret kronisk myelomonocytleukæmi (mcmml) i henhold til french american british - (fab -) klassifikationen.

Bulgarian

Клинична ефикасност и безопасност Ефикасността и безопасността на vidaza са били проучени в едно международно, многоцентрово, контролирано, отворено, рандомизирано, с паралелни групи сравнително проучване от фаза 3 (aza ph gl 2003 cl 001) при пациенти с:

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Get a better translation with
7,746,544,407 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK